Implement extraction compatibility with whole blood and tissue lysates with industry acceptable biosafety standards that include sterilization and produce an instrument designed with portability and…
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93023C00029
- Awardee
-
Redbud Labs, Inc. UEI KJGXVMFV9U14
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,799,353
Award facts
- Contract value 100% obligated
- $1,799,353.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $1,799,353 |
About this award
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), awarded a $1,799,353.00 Small Business Innovation Research (SBIR) Program Phase I contract to Redbud Labs, Inc., a for-profit microfluidic chip manufacturer. The contract is a firm fixed price definitive contract to implement extraction compatibility with whole blood and tissue lysates, producing a portable and rapidly installable instrument that meets industry biosafety standards including sterilization, for use in low resource environments. The work will be performed in Research Triangle Park, North Carolina from September 2023 through September 2026. This contract award is set aside for small businesses.
Description
Implement extraction compatibility with whole blood and tissue lysates with industry acceptable biosafety standards that include sterilization and produce an instrument designed with portability and rapid installation in low resource environments. TH
Quick answers
Who was awarded contract 75N93023C00029?
75N93023C00029 was awarded to Redbud Labs, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 15, 2023.
How much is contract 75N93023C00029 worth?
The government has obligated $1,799,353 on 75N93023C00029.
Was contract 75N93023C00029 competed?
The extent of competition for 75N93023C00029 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award